Long-term treatment with anakinra and canakinumab resolves patellar subchondral erosion in neonatal-onset multisystem inflammatory disease. [electronic resource]
Producer: 20191129Description: 53-55 p. digitalISSN:- 0048-7449
- Adolescent
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents -- therapeutic use
- Bone Diseases, Developmental -- diagnostic imaging
- Cryopyrin-Associated Periodic Syndromes -- drug therapy
- Humans
- Interleukin 1 Receptor Antagonist Protein -- therapeutic use
- Magnetic Resonance Imaging
- Male
- Patella -- diagnostic imaging
- Young Adult
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.